Fig. 2From: Multi-omics integration for neuroblastoma clinical endpoint predictionClassification performance on all endpoints considered in the study: by classifier for the 498 (panels a and b) and the 145 (panels c and d) sample subsets, as well as by platform (panels e and f) for both sample subsetsBack to article page